Activation of proMMP-2 and Src by HHV8 vGPCR in human pulmonary arterial endothelial cells

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 3, 2007, Pages 517-525

  Shan, Bin ^a   Morris, Cindy A ^a   Zhuo, Ying ^a   Shelby, Bryan D ^a   Levy, Dawn R ^a   Lasky, Joseph A ^a  

^a Section of Pulmonary Diseases   (United States)

Author keywords

Angiogenesis; MMP 2; Pulmonary hypertension; Src; vGPCR

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; GELATINASE A; MATRIX METALLOPROTEINASE 14; PROTEIN TYROSINE KINASE;

ARTICLE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HERPESVIRUS 8, HUMAN; HUMANS; MATRIX METALLOPROTEINASE 8; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ARTERY; RECEPTORS, G-PROTEIN-COUPLED; SRC-FAMILY KINASES; VIRAL PROTEINS;

HUMAN HERPESVIRUS 8; MURINAE;

EID: 33847635753     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.08.004     Document Type: Article

References (39)

1. Jenner R.G., and Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602 (2002) 1-22
2. Cool C.D., Rai P.R., Yeager M.E., Hernandez-Saavedra D., Serls A.E., Bull T.M., et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N. Engl. J. Med. 349 (2003) 1113-1122
3. Daibata M., Miyoshi I., Taguchi H., Matsubara H., Date H., Shimizu N., et al. Absence of human herpesvirus 8 in lung tissues from Japanese patients with primary pulmonary hypertension. Respir. Med. 98 (2004) 1231-1232
4. Laney A.S., De Marco T., Peters J.S., Malloy M., Teehankee C., Moore P.S., et al. Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension. Chest 127 (2005) 762-767
5. Henke-Gendo C., Mengel M., Hoeper M.M., Alkharsah K., and Schulz T.F. Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 172 (2005) 1581-1585
6. Montaner S., Sodhi A., Molinolo A., Bugge T.H., Sawai E.T., He Y., et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3 (2003) 23-36
7. Sodhi A., Montaner S., and Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat. Rev., Mol. Cell Biol. 5 (2004) 998-1012
8. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3 (2003) 422-433
9. Sounni N.E., Janssen M., Foidart J.M., and Noel A. Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol. 22 (2003) 55-61
10. Rosano L., Spinella F., Di Castro V., Nicotra M.R., Albini A., Natali P.G., et al. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am. J. Pathol. 163 (2003) 753-762
11. Sgadari C., Barillari G., Toschi E., Carlei D., Bacigalupo I., Baccarini S., et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat. Med. 8 (2002) 225-232
12. Benelli R., Adatia R., Ensoli B., Stetler-Stevenson W.G., Santi L., and Albini A. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol. Res. 6 (1994) 251-257
13. Frisdal E., Gest V., Vieillard-Baron A., Levame M., Lepetit H., Eddahibi S., et al. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur. Respir. J. 18 (2001) 838-845
14. Schermuly R.T., Kreisselmeier K.P., Ghofrani H.A., Samidurai A., Pullamsetti S., Weissmann N., et al. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Circ. Res. 94 (2004) 1101-1108
15. Cowan K.N., Heilbut A., Humpl T., Lam C., Ito S., and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat. Med. 6 (2000) 698-702
16. Boggon T.J., and Eck M.J. Structure and regulation of Src family kinases. Oncogene 23 (2004) 7918-7927
17. Luttrell D.K., and Luttrell L.M. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23 (2004) 7969-7978
18. Shan B., Zhuo Y., Chin D., Morris C.A., Morris G.F., and Lasky J.A. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells. J. Biol. Chem. 280 (2005) 1103-1111
19. Galvez B.G., Matias-Roman S., Albar J.P., Sanchez-Madrid F., and Arroyo A.G. Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J. Biol. Chem. 276 (2001) 37491-37500
20. Hidai C., Zupancic T., Penta K., Mikhail A., Kawana M., Quertermous E.E., et al. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev. 12 (1998) 21-33
21. Pati S., Cavrois M., Guo H.G., Foulke Sr. J.S., Kim J., Feldman R.A., et al. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol. 75 (2001) 8660-8673
22. Heidemann J., Ogawa H., Dwinell M.B., Rafiee P., Maaser C., Gockel H.R., et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 278 (2003) 8508-8515
23. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell Biol. 17 (1997) 4015-4023
24. Galvez B.G., Genis L., Matias-Roman S., Oblander S.A., Tryggvason K., Apte S.S., et al. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J. Biol. Chem. 280 (2005) 1292-1298
25. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
26. Wang Z., Juttermann R., and Soloway P.D. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275 (2000) 26411-26415
27. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., van Westrum S.S., et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273 (1998) 871-880
28. Koike T., Vernon R.B., Gooden M.D., Sadoun E., and Reed M.J. Inhibited angiogenesis in aging: a role for TIMP-2. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 58 (2003) B798-B805
29. Li H., Lindenmeyer F., Grenet C., Opolon P., Menashi S., Soria C., et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum. Gene Ther. 12 (2001) 515-526
30. Playford M.P., and Schaller M.D. The interplay between Src and integrins in normal and tumor biology. Oncogene 23 (2004) 7928-7946
31. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2 (2000) 737-744
32. Ohno-Matsui K., Uetama T., Yoshida T., Hayano M., Itoh T., Morita I., et al. Reduced retinal angiogenesis in MMP-2-deficient mice. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5370-5375
33. Fujita M., Shannon J.M., Irvin C.G., Fagan K.A., Cool C., Augustin A., et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am. J. Physiol., Lung Cell. Mol. Physiol. 280 (2001) L39-L49
34. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
35. Orr A.W., and Murphy-Ullrich J.E. Regulation of endothelial cell function BY FAK and PYK2. Front. Biosci. 9 (2004) 1254-1266
36. Kim I., Kim H.G., Moon S.O., Chae S.W., So J.N., Koh K.N., et al. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ. Res. 86 (2000) 952-959
37. Daniels C.E., Wilkes M.C., Edens M., Kottom T.J., Murphy S.J., Limper A.H., et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114 (2004) 1308-1316
38. Windham T.C., Parikh N.U., Siwak D.R., Summy J.M., McConkey D.J., Kraker A.J., et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene 21 (2002) 7797-7807
39. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., and Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394 (1998) 588-592